Your Heart Skips. Your Genes May Explain Why.

NOS3 produces nitric oxide in your endothelial cells, the thin layer lining your blood vessels. This gas is a signaling molecule that tells your arteries to relax and dilate, allowing blood to flow freely and blood pressure to normalize. Without adequate nitric oxide, your vessels stay constricted, and your heart must work harder to pump against resistance.

The Glu298Asp variant in NOS3, carried by roughly 30-40% of the population, reduces the enzyme’s ability to produce nitric oxide effectively. This means your blood vessels stay stiffer than they should, forcing your heart to generate higher pressure to move blood through them. Higher pressure creates turbulent flow, which irritates the vessel walls and triggers inflammation. Your heart compensates by beating faster and more irregularly, and your baseline blood pressure climbs.

You feel this as palpitations especially during or after exertion, when your blood vessels should dilate but can’t. Your resting heart rate runs higher than expected. You may notice you feel flushed or get headaches more easily than others. Your blood pressure drifts upward over time, and you’re surprised to learn you’re developing hypertension in your 40s or 50s despite being lean.

ACE is an enzyme that converts angiotensin I into angiotensin II, a powerful vasoconstrictor hormone. When your blood pressure drops, your kidneys release angiotensin I as a signal. ACE catches it and converts it to angiotensin II, which tightens your arteries and raises pressure back up. This is a critical survival mechanism. But like all systems, balance matters.

The D/D polymorphism in ACE, present in roughly 25% of the population, causes your body to produce too much angiotensin II. Your vessels are constantly constricted, your blood pressure runs high, and your heart must pump against chronic resistance. Over time, this pressure overload causes the heart’s left ventricle to thicken (called hypertrophic remodeling), distorting the electrical pathways. The thickened, stiffened heart becomes prone to arrhythmia as electrical signals struggle to propagate through scar tissue and enlarged muscle.

You experience this as a racing heart, especially when you feel angry or stressed (when angiotensin II naturally spikes). Your blood pressure is often elevated even at rest. You may notice that high-sodium foods make your palpitations worse, because salt amplifies angiotensin II’s effects. You develop a sense of heaviness in your chest, and over years, your doctor mentions that your heart is getting thicker on the echo.

MTHFR converts folate into its active form, 5-methyltetrahydrofolate, which your cells use to run the methylation cycle. This cycle produces the methyl groups that regulate homocysteine, a compound that is toxic to blood vessels in high amounts. Homocysteine is the intermediate: your cells either methylate it into methionine (safe) or break it down via transsulfuration (also safe). Either way, it doesn’t accumulate. When MTHFR is impaired, this doesn’t happen efficiently.

The C677T variant in MTHFR, carried by roughly 40% of the population in European ancestry, reduces enzyme efficiency by 40-70%. Your cells convert folate slowly and produce less 5-methyltetrahydrofolate. Homocysteine begins to accumulate in your bloodstream, where it damages vessel walls, promotes blood clotting, and triggers chronic inflammation in your arteries. This process is called homocysteinuria, though doctors rarely screen for it.

You experience this as palpitations that seem to come and go without clear trigger. You may have had a cardiovascular event (like a small stroke or heart attack) in your 30s or 40s, far earlier than would be typical for your family. Your family history is unremarkable for heart disease, yet you’re the outlier. You feel fatigued and notice your brain fog worsens in the afternoons, reflecting poor methylation throughout your body.

COMT is an enzyme that breaks down catecholamine neurotransmitters: dopamine, norepinephrine, and epinephrine (adrenaline). When you face a stressor, your adrenal gland floods your bloodstream with adrenaline to activate your heart, lungs, and muscles. COMT is responsible for cleaning up this hormone once the threat passes. When COMT works quickly, stress hormones spike briefly then fall. Your heart returns to normal rhythm and your nervous system recovers.

The Val158Met variant in COMT, found in roughly 25% of the population as homozygous slow, dramatically slows adrenaline clearance. Catecholamines remain in your bloodstream and brain long after the stressor has passed. Your nervous system stays in fight-or-flight mode for hours, keeping your heart rate elevated, blood pressure high, and your heart irritable and prone to ectopic beats. The repeated electrical noise from excess adrenaline remodels your heart’s conduction system, sensitizing it to future arrhythmias.

You feel this as a racing heart in response to seemingly minor stressors. Anxiety conversations, traffic, even anticipation of an event sets off palpitations that linger for hours. You’re told you’re “wired” or anxious, but you don’t feel anxious. Your heart just won’t settle. You may notice that stimulants like caffeine cause severe palpitations, while alcohol helps you calm down (because it slows COMT-mediated clearance by blocking dopamine metabolism). You startle easily and feel your heart pound.

SCN5A encodes the voltage-gated sodium channel that initiates each heartbeat’s electrical impulse. When your heart’s SA node fires, sodium ions rush into cardiac muscle cells, depolarizing them and triggering contraction. SCN5A is the gatekeeper for this first critical step. A properly functioning sodium channel ensures the electrical signal propagates evenly across the heart. When SCN5A is variant, sodium doesn’t flow properly, and the electrical wavefront becomes ragged or slowed.

Variants in SCN5A are found in roughly 5-10% of people with inherited arrhythmia syndromes, though population frequency is low. When present, they markedly shorten the action potential duration or slow conduction velocity. This creates areas of electrical dead time where the signal hesitates, splits, or bounces back, triggering reentrant arrhythmias like atrial fibrillation or ventricular tachycardia. Some SCN5A variants are “temperature sensitive,” meaning arrhythmias spike during fever, particularly dangerous.

You experience this as sudden, unprovoked episodes of rapid palpitations that feel like your heart is racing at 150+ beats per minute. These episodes may be triggered by exercise, emotion, or fever, but sometimes appear spontaneous. You may have been diagnosed with long QT syndrome, Brugada syndrome, or inherited arrhythmia. You’ve been told these conditions can be dangerous and sometimes even fatal, and you’re afraid to exercise hard or sleep in a warm room.

KCNQ1 encodes the potassium channel that allows potassium ions to exit cardiac muscle cells during the repolarization phase of each heartbeat. After the sodium rush that depolarizes the cell, potassium must flow out to restore the cell’s negative resting charge, resetting it for the next beat. Without proper potassium efflux, the cell stays depolarized too long, the action potential is abnormally prolonged, and the electrical timing across the heart becomes chaotic.

Variants in KCNQ1, found in roughly 5-10% of people with inherited long QT syndrome, impair potassium channel function. Repolarization is delayed, the QT interval on the EKG lengthens, and the heart becomes susceptible to torsades de pointes, a life-threatening polymorphic ventricular arrhythmia that causes sudden syncope or cardiac arrest. Like SCN5A variants, KCNQ1 variants are often temperature or exercise-sensitive, meaning arrhythmias spike during exertion or fever.

You experience this as syncope (fainting) during exercise, swimming, or emotional stress, sometimes without warning palpitations. You may have a family history of sudden cardiac death in young relatives, which alarmed you into seeking testing. Your EKG shows a prolonged QT interval. You’ve been warned to avoid strenuous activity, and you feel the weight of living with a potentially fatal arrhythmia syndrome.